Financial results - SANFER PHARM SRL

Financial Summary - Sanfer Pharm Srl
Unique identification code: 35801346
Registration number: J26/391/2016
Nace: 4729
Sales - Ron
48.806
Net Profit - Ron
3.359
Employee
The most important financial indicators for the company Sanfer Pharm Srl - Unique Identification Number 35801346: sales in 2023 was 48.806 euro, registering a net profit of 3.359 euro and having an average number of employees. Firma isi desfasoara activitatea in domeniul Comert cu amanuntul al altor produse alimentare, in magazine specializate having the NACE code 4729.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Sanfer Pharm Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - 4.857 19.078 12.182 21.892 27.688 45.469 50.392 48.806
Total Income - EUR - - 4.857 19.078 12.182 21.892 27.688 45.469 50.417 53.317
Total Expenses - EUR - - 4.394 14.448 9.805 16.897 20.546 39.686 45.992 49.303
Gross Profit/Loss - EUR - - 463 4.629 2.377 4.996 7.142 5.783 4.424 4.014
Net Profit/Loss - EUR - - 318 4.057 2.012 4.339 6.311 4.582 3.138 3.359
Employees - - 0 0 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -2.9%, from 50.392 euro in the year 2022, to 48.806 euro in 2023. The Net Profit increased by 230 euro, from 3.138 euro in 2022, to 3.359 in the last year.

Check the financial reports for the company - Sanfer Pharm Srl

Rating financiar

Financial Rating -
Sanfer Pharm Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Sanfer Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Sanfer Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Sanfer Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Sanfer Pharm Srl - CUI 35801346

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - 540 402 269 273 195 119 69 30
Current Assets - - 3.857 6.953 11.527 16.587 23.504 25.276 27.473 22.832
Inventories - - 2.309 2.989 1.395 2.864 5.034 5.957 12.747 9.680
Receivables - - 0 431 438 429 0 259 61 0
Cash - - 1.548 3.534 9.694 13.294 18.470 19.061 14.664 13.152
Shareholders Funds - - 362 4.413 6.344 10.559 16.671 18.756 21.952 19.399
Social Capital - - 45 44 43 42 41 40 41 40
Debts - - 4.034 2.943 5.452 6.300 7.028 6.639 5.589 3.462
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4729 - 4729"
CAEN Financial Year 4729
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 22.832 euro in 2023 which includes Inventories of 9.680 euro, Receivables of 0 euro and cash availability of 13.152 euro.
The company's Equity was valued at 19.399 euro, while total Liabilities amounted to 3.462 euro. Equity decreased by -2.487 euro, from 21.952 euro in 2022, to 19.399 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Sanfer Pharm Srl

Comments - Sanfer Pharm Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.